MedTrace Logo

Effect of Dry Needling Versus Kinesiology Taping in Patient With Plantar Fasciitis

NCT07118397 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2025-08-12

No results posted yet for this study

Summary

A single-blinded randomized controlled trial was conducted at hamza hospital Lahore ,Lahore poly clinic over 9 months. A total of 60 participants aged 20-45 years with clinically diagnosed plantar fasciitis and identifiable myofascial trigger points were recruited using a non-probability purposive sampling technique. They were randomly assigned to two groups (n=30 each): Group A received dry needling with conventional physiotherapy once per week, while Group B received kinesiology taping with conventional physiotherapy twice per week. Both interventions were administered for 6 weeks. Outcome measures included the Visual Analogue Scale (VAS) for pain, Foot and Ankle Outcome Score (FAOS) for functional assessment, and SF-12 Health Survey for quality of life. Assessments were conducted at baseline, week 3, and week 6.

Conditions

  • Plantar Fasciitis of Both Feet

Interventions

OTHER

dry needling

Dry needling involved the insertion of fine needles into identified myofascial trigger points within the plantar fascia and associated muscles. The technique aimed to release muscle tightness and alleviated pain by stimulating the trigger points. Needles were inserted perpendicularly to the skin at the identified trigger points, with the depth of insertion typically ranged from 35 to 70 mm, with 0.30mm diameter.

OTHER

kinesiology taping

Kinesiology Taping was applied using an I-shape technique. The taping began from the metatarsal head, extending through the plantar fascia and along the Achilles' tendon to the calf muscle. The application involved specific tension levels to support the plantar fascia and improve functional movement. The taping was applied with the foot in a slightly dorsiflexed position to ensure proper adherence and function.

Sponsors & Collaborators

  • University of Lahore

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-01-14
Primary Completion
2025-08-10
Completion
2025-08-31

Countries

  • Pakistan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07118397 on ClinicalTrials.gov